SGPL1 and cystic fibrosis: For instance, inhibiting shared SPL activity in both the host and A. fumigatus could prove beneficial in cystic fibrosis (CF), as elevated S1P levels elicit disparate effects in the host and the fungal pathogen, ultimately leading to an enhanced antifungal response.